Lecanemab Planning
The planning process for lecanemab can serve as a blueprint to support safe and effective management of therapeutic innovation in neurology and other areas.
Authors
- Thanh G. Tu (ORCID: https://orcid.org/0000-0001-8209-6955)
- Sarah Kremen (ORCID: https://orcid.org/0000-0003-2593-0602)
- Nancy L. Sicotte (ORCID: https://orcid.org/0000-0002-5131-3352)
- Zaldy S. Tan (ORCID: https://orcid.org/0000-0002-4588-1206)
- Rita Shane (ORCID: https://orcid.org/0009-0000-8560-6244)
- Hai Tran (ORCID: https://orcid.org/0000-0002-9043-1941)
Institutions
- Cedars-Sinai Medical Center (US)
Publication Details
- Journal
- Neurology Clinical Practice
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1212/cpj.0000000000200361
- Citations
- 4
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 4.52